Top Markets
Coin of the day
Organicell Regenerative Medicine, Inc. Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.

OCEL
Classifica tra le azioni #31539
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical... Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.
Prezzo delle azioni
$1.77
Ultima sincronizzazione: 2024-04-02
Capitalizzazione di mercato
$12.89M
Variazione (1 giorno)
-11.50%
Variazione (1 anno)
0.00%
Paese
US
Scambia Organicell Regenerative Medicine, Inc. (OCEL)

Categoria

Storico del prezzo dell'azione per Organicell Regenerative Medicine, Inc. (OCEL)
Prezzo di chiusura più alto: $1.89 il 2024-04-01

Prezzo di chiusura più basso: $117.90 il 2016-03-01
Storico del prezzo dell'azione di Organicell Regenerative Medicine, Inc. dal 2016 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 42.05%
2023 -70.50%
2022 -42.43%
2021 -72.54%
2020 504.63%
2019 263.71%
2018 -40.90%
2017 -91.64%
2016 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$515.58 32.24%
US
$992.01 50.00%
NL
$111.31 -36.83%
AU
$734.30 6.65%
CH
$1.06K -7.04%
KR